000909067 001__ 909067
000909067 005__ 20230123101848.0
000909067 0247_ $$2doi$$a10.3389/fnins.2021.696440
000909067 0247_ $$2pmid$$apmid:34326719
000909067 0247_ $$2pmc$$apmc:PMC8313869
000909067 0247_ $$2ISSN$$a1662-453X
000909067 0247_ $$2ISSN$$a1662-4548
000909067 0247_ $$2Handle$$a2128/31656
000909067 0247_ $$2WOS$$aWOS:000878869900001
000909067 037__ $$aFZJ-2022-02985
000909067 041__ $$aEnglish
000909067 082__ $$a610
000909067 1001_ $$0P:(DE-HGF)0$$aSzegő, Éva M$$b0
000909067 245__ $$aA β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons.
000909067 260__ $$aLausanne$$bFrontiers Research Foundation$$c2021
000909067 3367_ $$2DRIVER$$aarticle
000909067 3367_ $$2DataCite$$aOutput Types/Journal article
000909067 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1661165417_2172
000909067 3367_ $$2BibTeX$$aARTICLE
000909067 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000909067 3367_ $$00$$2EndNote$$aJournal Article
000909067 520__ $$aReducing α-synuclein pathology constitutes a plausible strategy against Parkinson's disease. As we recently demonstrated, the β-wrapin protein AS69 binds an N-terminal region in monomeric α-synuclein, interferes with fibril nucleation, and reduces α-synuclein aggregation in vitro and in a fruit fly model of α-synuclein toxicity. The aim of this study was to investigate whether AS69 also reduces α-synuclein pathology in mammalian neurons. To induce α-synuclein pathology, primary mouse neurons were exposed to pre-formed fibrils (PFF) of human α-synuclein. PFF were also injected into the striatum of A30P-α-synuclein transgenic mice. The extent of α-synuclein pathology was determined by phospho-α-synuclein staining and by Triton X-100 solubility. The degeneration of neuronal somata, dendrites, and axon terminals was determined by immunohistochemistry. AS69 and PFF were taken up by primary neurons. AS69 did not alter PFF uptake, but AS69 did reduce PFF-induced α-synuclein pathology. PFF injection into mouse striatum led to α-synuclein pathology and dystrophic neurites. Co-injection of AS69 abrogated PFF-induced pathology. AS69 also reduced the PFF-induced degeneration of dopaminergic axon terminals in the striatum and the degeneration of dopaminergic dendrites in the substantia nigra pars reticulata. AS69 reduced the activation of astroglia but not microglia in response to PFF injection. Collectively, AS69 reduced PFF-induced α-synuclein pathology and the associated neurodegeneration in primary neurons and in mouse brain. Our data therefore suggest that small proteins binding the N-terminus of α-synuclein monomers are promising strategies to modify disease progression in Parkinson's disease.
000909067 536__ $$0G:(DE-HGF)POF4-5244$$a5244 - Information Processing in Neuronal Networks (POF4-524)$$cPOF4-524$$fPOF IV$$x0
000909067 536__ $$0G:(EU-Grant)726368$$aBETACONTROL - Control of amyloid formation via beta-hairpin molecular recognition features (726368)$$c726368$$fERC-2016-COG$$x1
000909067 588__ $$aDataset connected to DataCite
000909067 650_7 $$2Other$$amolecular chaperones
000909067 650_7 $$2Other$$ananobodies
000909067 650_7 $$2Other$$apre-formed fibrils
000909067 650_7 $$2Other$$aprotein aggregation
000909067 650_7 $$2Other$$aα-synuclein
000909067 7001_ $$0P:(DE-HGF)0$$aBoß, Fabian$$b1
000909067 7001_ $$0P:(DE-HGF)0$$aKomnig, Daniel$$b2
000909067 7001_ $$0P:(DE-HGF)0$$aGärtner, Charlott$$b3
000909067 7001_ $$0P:(DE-HGF)0$$aHöfs, Lennart$$b4
000909067 7001_ $$0P:(DE-Juel1)167315$$aShaykhalishahi, Hamed$$b5
000909067 7001_ $$0P:(DE-HGF)0$$aWördehoff, Michael M$$b6
000909067 7001_ $$0P:(DE-HGF)0$$aSaridaki, Theodora$$b7
000909067 7001_ $$0P:(DE-Juel1)171786$$aSchulz, Jörg B$$b8$$ufzj
000909067 7001_ $$0P:(DE-Juel1)166306$$aHoyer, Wolfgang$$b9$$ufzj
000909067 7001_ $$0P:(DE-HGF)0$$aFalkenburger, Björn H$$b10$$eCorresponding author
000909067 773__ $$0PERI:(DE-600)2411902-7$$a10.3389/fnins.2021.696440$$gVol. 15, p. 696440$$p696440$$tFrontiers in neuroscience$$v15$$x1662-453X$$y2021
000909067 8564_ $$uhttps://juser.fz-juelich.de/record/909067/files/Szego%202021%20Front%20Neurosci.pdf$$yOpenAccess
000909067 909CO $$ooai:juser.fz-juelich.de:909067$$pdnbdelivery$$pec_fundedresources$$pVDB$$pdriver$$popen_access$$popenaire
000909067 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)171786$$aForschungszentrum Jülich$$b8$$kFZJ
000909067 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166306$$aForschungszentrum Jülich$$b9$$kFZJ
000909067 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5244$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
000909067 9141_ $$y2022
000909067 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-05-04
000909067 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000909067 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000909067 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT NEUROSCI-SWITZ : 2019$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-05-04
000909067 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-05-04
000909067 920__ $$lno
000909067 9201_ $$0I:(DE-Juel1)IBI-7-20200312$$kIBI-7$$lStrukturbiochemie$$x0
000909067 980__ $$ajournal
000909067 980__ $$aVDB
000909067 980__ $$aUNRESTRICTED
000909067 980__ $$aI:(DE-Juel1)IBI-7-20200312
000909067 9801_ $$aFullTexts